Image

Heroin, methadone, buprenorphine, morphine, MS-Contin, OxyContin, oxycodone, and other opioid analgesics.
Yes, the RODS was originally developed to support rapid assessment of individuals experiencing incarceration with HIV to allow buprenorphine induction on the day of release, if necessary.
The RODS has shown good-to-strong sensitivity (97%) and specificity (76%) among clients with HIV. Researchers have suggested that it is an ideal first-line assessment tool for this reason, but validity tests were conducted specifically with individuals experiencing incarceration with a relatively small sample size.